Clinical Trial Update: Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer [NA]

View source ↗

Summary

A pilot study evaluating whole-gland salvage HDR prostate brachytherapy for locally recurrent prostate cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Cancer Recurrent | NA | Status: ACTIVE_NOT_RECRUITING